Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Precision Neuroscience Acquires U.S. Manufacturing Facility and Receives FDA Breakthrough Device Designation

NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced it has acquired a microelectromechanical systems (MEMS) foundry outside Dallas, TX. The facility acquisition, completed through a wholly owned subsidiary, Precision BioMEMS Corporation, brings the company’s supply chain in-house and establishes Precision as one of the leading-edge manufacturers of biomedical MEMS in the United States. Further, the company also announced that its system has been awarded Breakthrough Device designation from the U.S. Food and Drug Administration. The designation expedites the review of new technologies designed to treat debilitating or life-threatening conditions.

Founded in 2021 by a team including neurosurgeon Benjamin Rapoport and business leader Michael Mager, Precision has created a direct communication pathway between the human brain and computers. The company completed first-in-human clinical studies of its device in April, mapping the human brain’s activity at an unprecedented level of detail. In coming years, the company anticipates that its minimally invasive brain implant will enable people with severe neurological conditions such as speech deficits and paralysis to regain independence, communicate with loved ones, and rejoin the workforce. The foundry acquisition gives Precision full production control of its core technology—a thin-film microelectrode array, called the Layer 7 Cortical Interface, which packs 1,024 electrodes into an area spanning 1.5 square centimeters—enabling a greater degree of quality management and the ability to iterate rapidly on future versions.

The facility comprises a 22,000 square foot building, including a 5,500 square foot ISO class 5 clean room (a low-particle zone for manufacturing), more than 500 square feet of ISO class 6 post-processing and assembly space, and over fifty specialized tools. Precision BioMEMS retained the facility’s team, which has deep expertise in both biomedical and general-purpose MEMS manufacturing. In addition to its work for Precision, Precision BioMEMS will continue to operate as a foundry serving other cutting-edge companies in the United States.

“To deliver brain–computer interface technology to the millions of people who stand to benefit, we need to rethink the medical device supply chain,” said Michael Mager, Precision’s CEO. “High precision microfabrication is critical to building powerful brain–computer interfaces, and it will play an increasingly important role in medical device manufacturing going forward. Precision BioMEMS will help us build the neural technology of tomorrow while also advancing the broader U.S. medical device industry.”

Precision’s brain–computer interface is an investigational device and is not available for sale in the United States.

About Precision Neuroscience
Precision Neuroscience is working to provide breakthrough treatments for the millions of people worldwide suffering from neurological illnesses. The company is building the only brain–computer interface designed to be minimally invasive, safely removable, and capable of processing large amounts of data. To learn more about how Precision is connecting human intelligence and artificial intelligence, visit www.precisionneuro.io.

Contact: media@precisionneuro.io


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.